CONMED | CNMD - Les Charges D'Exploitation

Prix De L'Action
36.66
Variation Quotidienne
0 0%
Mensuellement
5.38%
Annuel
-36.44%
Q2 Prévisions
37.52




Les Charges D'Exploitation Changement Date
3M USD 3.26B 1.66B 2026-03
Abbott USD 9.31B 104M 2026-03
Accuray USD 37.18M 567K 2024-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.15B 107M 2026-03
CONMED USD 291.63M 44.94M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 337.72M 2.02M 2026-03
Olympus JPY 233.04B 18.77B 2025-12
Orthofix International USD 213.79M 12.36M 2025-12
ResMed USD 925.74M 525K 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Steris USD 1.22B 28.8M 2025-12
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03